WHO ICTRP trial
Comparative study of KSM-66 Ashwagandha (Withania somnifera) in Adults…
CTRI/2020/03/024186 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2020/03/024186 |
|---|---|
| Public title | Comparative study of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety |
| Scientific title | Prospective, Randomized, Multi-centric, Double-Blind Placebo-Controlled Study Evaluating the Efficacy and Safety of KSM-66 Ashwagandha (Withania somnifera) in Adults Experiencing High Stress and/or Anxiety |
| Primary sponsor | Shri Kartikeya Pharma Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | Australia;India;Spain;United States of America |
| Conditions | Health Condition 1: G968- Other specified disorders of central nervous system |
| Interventions | Intervention1: Ashwagandha extract 300 mg (KSM66 capsule): One capsule contains 300 mg Ashwagandha extract. One capsule to be taken orally with water two times daily for 8 weeks Control Intervention1: Capsule identical to study capsule: One… |
| Registration date | Mar 23, 2020 |
| Target size | 1000 |
| Secondary IDs | KSM66/PMS/2018/09 Version 3.0 dt. 21-01-2020 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: